PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33432012-1	2021	Tacrolimus (TAC) pharmacokinetics is influenced by the donor CYP3A5 genotype and the age of pediatric liver recipients.	Tacrolimus	0-10	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	61-67	
33432012-1	2021	Tacrolimus (TAC) pharmacokinetics is influenced by the donor CYP3A5 genotype and the age of pediatric liver recipients.	Tacrolimus	12-15	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	61-67	
33432012-6	2021	TAC concentration/weight-adjusted dose ratio was significantly lower in recipients from CYP3A5*1/*3 donors or with extra-large (GRWR > 5%) or large (GRWR 3-5%) grafts.	Tacrolimus	0-3	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	88-94	
33432012-9	2021	In conclusion, TAC starting dose could be guided according to the donor CYP3A5 genotype and GRWR, allowing for a quicker achievement of target concentrations and eventually reducing the risk of rejection.	Tacrolimus	15-18	cytochrome P450 family 3 subfamily A member 5	Homo sapiens	72-78